BBarclays XXPeng · XPEV

Barclays Comments on XPeng’s Q1 Results

May 23, 2025· 1 min read· Reproduced verbatim
Rating
Hold
Price target
$20
Previous
Implied downside
-2%

“1Q results came in broadly in line and the story will most depend on the success or lack of of the new models XPEV is launching in the months ahead. Maintain UW and PT $20.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Privacy Preference Center

Share on